Johnson & Johnson wins FDA approval for TECNIS PureSee intraocular lens in U.S. cataract surgery

Reuters03-12 20:03
Johnson & Johnson wins FDA approval for TECNIS PureSee intraocular lens in U.S. cataract surgery

Johnson & Johnson said the FDA approved the TECNIS PureSee intraocular lens for use in cataract surgery. The company said the lens is an extended depth of focus option intended to address cataract-related vision loss and presbyopia. Johnson & Johnson said 97% of patients reported no very bothersome visual disturbances in a study referenced in the announcement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief via Business Wire (Ref. ID: 20260312338552) on March 12, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment